TR-367: Phenylbutazone (50-33-9)
Study Results
Chronic Bioassay Level of Evidence
Rats | |
---|---|
View
|
Mice | |
---|---|
View
|
Genetic Toxicology
Mammalian Cell Mutagenicity |
---|
View
|
Mammalian Cell Cytogenetics | |
---|---|
CA | SCE |
|
|
Bacterial Mutagenicity |
---|
View
|
Publications
TR-367
Toxicology and Carcinogenesis Studies of Phenylbutazone (CASRN 50-33-9) in F344/N Rats and B6C3F1 Mice (Gavage Studies)
Study Data
Toxicity and Carcinogenicity Studies
Evaluation of the Chronic Toxicity and Carcinogenicity (C56531) of Phenylbutazone (50-33-9) in F344/N Rats Exposed via Gavage
Pathology Tables
Individual Animal Data
- Male Individual Animal Body Weight Data
- Male Individual Animal Organ Weight Data
- Male Individual Animal Pathology Data Neoplastic
- Male Individual Animal Pathology Data Non Neoplastic
- Male Individual Animal Survival Data
- Female Individual Animal Body Weight Data
- Female Individual Animal Organ Weight Data
- Female Individual Animal Pathology Data Neoplastic
- Female Individual Animal Pathology Data Non Neoplastic
- Female Individual Animal Survival Data
Evaluation of the Chronic Toxicity and Carcinogenicity (C56531) of Phenylbutazone (50-33-9) in B6C3F1 Mice Exposed via Gavage
Pathology Tables
Individual Animal Data
- P14 - Female,Male Individual Animal Pathology Data
- Male Individual Animal Organ Weight Data
- Male Individual Animal Pathology Data Neoplastic
- Male Individual Animal Pathology Data Non Neoplastic
- Male Individual Animal Survival Data
- Female Individual Animal Organ Weight Data
- Female Individual Animal Pathology Data Neoplastic
- Female Individual Animal Pathology Data Non Neoplastic
- Female Individual Animal Survival Data
Genetic Toxicology Studies
Genetic Toxicity Evaluation of Phenylbutazone in Salmonella/E.coli Mutagenicity Test or Ames Test. Study 030078
Summary Data
- G06 - Ames Summary Data (129 KB)